Precise anatomical resection based on structures of nerve and fibrous tissue around the superior mesenteric artery for mesopancreas dissection in pancreaticoduodenectomy for pancreatic cancer
Authors:
- 11 February 2020
- journal article
- research article
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 27 (6) , 342-351
Abstract
Background: The aim of the present study was to investigate the feasibility of resection based on the nerve and fibrous tissue (NFT) structures around the superior mesenteric artery (SMA) for resectable pancreatic adenocarcinoma (R‐PDAC) patients.Methods: NFTs around the SMA were classified into four “intensive NTFs area” with spreading the NFTs around the SMA and three SMA nerve plexus regions without branching nerves according to autopsy findings. Complete dissection of four “intensive NTFs areas” was performed by pre‐exposing three SMA nerve plexus regions without branching nerves as “dissection‐guiding points” with SMA nerve plexus preservation (NFT‐based resection). Among 157 R‐PDAC patients undergoing pancreaticoduodenectomy, surgical outcomes of 78 patients with NFT‐based resection were compared with 59 patients with half‐SMA nerve plexus dissection and 20 patients without NFTs dissection.Results: In the NFT‐based resection group, 76.5% had tumor involvement and metastasis in each intensive NTFs area. Operative time, blood loss, and postoperative diarrhea rate were significantly lower in NFT‐based resection than in half‐SMA nerve plexus group (321 vs 390 min; P < .01, 228 vs 550 mL; P < .01, 5.1% vs 15.3%; P = .04, respectively). R0 rate and median overall survival significantly improved in NFT‐based resection than in non‐NFT dissection group (93.6% vs 65.0%; P < .01, 49.6 vs 23.6 months, P = .01).Conclusion: NFT‐based resection may become a novel method for R‐PDAC patients.Keywords
This publication has 20 references indexed in Scilit:
- The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal AdenocarcinomaAnnals of Surgery, 2019
- R0 Versus R1 Resection Matters after Pancreaticoduodenectomy, and Less after Distal or Total Pancreatectomy for Pancreatic CancerAnnals of Surgery, 2018
- A Prospective Randomized Controlled Study Comparing Outcomes of Standard Resection and Extended Resection, Including Dissection of the Nerve Plexus and Various Lymph Nodes, in Patients With Pancreatic Head CancerAnnals of Surgery, 2014
- Mesopancreas: A boundless structure, namely R1 risk in pancreaticoduodenectomy for pancreatic head carcinomaEuropean Journal of Surgical Oncology, 2013
- Surgical technique and results of total mesopancreas excision (TMpE) in pancreatic tumorsEuropean Journal of Surgical Oncology, 2012
- Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreasJournal of Hepato-Biliary-Pancreatic Sciences, 2011
- The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trialsLangenbeck's Archives of Surgery, 2009
- Resection of the mesopancreas (RMP): a new surgical classification of a known anatomical spaceWorld Journal of Surgical Oncology, 2007
- A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinomaSurgery, 2005
- Standard Versus Extended Lymphadenectomy Associated With Pancreatoduodenectomy in the Surgical Treatment of Adenocarcinoma of the Head of the PancreasAnnals of Surgery, 1998